Attached you will find the newsletter from DHS Patentanwalts GmbH, provided to us by Dr. Stefan Danner.
In the last few months, the European Court of Justice (ECJ) has handed down several decisions relating to the grant and validity of supplementary protection certificates (SPCs; i.e. patent term extensions). Thereof, the following rulings are generally considered to have significant impact on IP strategies in the pharmaceutical industry.
